Extranodal NK-T-cell lymphoma historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{RG}} | {{CMG}}; {{AE}} {{RG}} | ||
== Overview == | == Overview == | ||
First known case of Natural-Killer-cell lymphoma was diagnosed in a 19-years old boy. The diagnosis of Natural-Killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out. | Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic [[granuloma]].First known case of Natural-Killer-cell lymphoma was diagnosed in a 19-years old boy. The diagnosis of Natural-Killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out. | ||
== Historical Perspective == | == Historical Perspective == |
Revision as of 14:31, 22 August 2019
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma historical perspective On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma historical perspective |
Extranodal NK-T-cell lymphoma historical perspective in the news |
Blogs on Extranodal NK-T-cell lymphoma historical perspective |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma.First known case of Natural-Killer-cell lymphoma was diagnosed in a 19-years old boy. The diagnosis of Natural-Killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
Historical Perspective
- Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma[1]
- The natural history of Extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "Rhinitis Gangrenosa Progressiva"[2]
- Since the lesions usually was in midline and was aggresive and lethal , the term "lethal midline granuloma (LMG)" was used.[3]
- First known case of Natural-Killer-cell lymphoma was a 19-years old man, with a tumor affecting nasal cavity.[4]
- Natural-Killer-cell lymphoma was diagnosed as "Granuloma Gangraenescens" which was considered as unclassified sarcoma.
- The diagnosis of Natural-Killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
- 33 years later, in 1998, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the leukemic disease.
- Reanalysis of stored slides of 1965 revealed an immunophenotype typical of NK cell which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood.
- Biopsy specimen collected in 1998 and 2002 contained EBV virus encoded RNA transcripts and then diagnosed as a Natural-killer-cell lymphoma.
References
- ↑ Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T (2019). "Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress". Front Pediatr. 7: 141. doi:10.3389/fped.2019.00141. PMC 6476925. PMID 31041299.
- ↑ McBride P (1991). "Photographs of a case of rapid destruction of the nose and face. 1897". J Laryngol Otol. 105 (12): 1120. doi:10.1017/s0022215100118407. PMID 1787378.
- ↑ Aozasa, Katsuyuki; Takakuwa, Tetsuya; Hongyo, Tadashi; Yang, Woo-Ick (2008). "Nasal NK/T-cell lymphoma: epidemiology and pathogenesis". International Journal of Hematology. 87 (2): 110–117. doi:10.1007/s12185-008-0021-7. ISSN 0925-5710.
- ↑ Schrader C, Janssen D, Kneba M, Lennert K (2004). "A 38-year history of natural-killer-cell lymphoma". N Engl J Med. 350 (4): 418–9. doi:10.1056/NEJM200401223500423. PMID 14736941.